Skip to main content
OpenTrials
Completed

NCT Number: NCT05898750

Antidiabetic Potiential of Moringa and Dom Extract

The Antidiabetic potential of Hyphaene thebaica fruits and Moringa oleifera leaves will be investigated in diabetic patients (type 2). The patients will be maintained on tea of both drugs for 6 weeks. The fasting blood glucose levels of patients will be checked on a daily basis. Other blood biomarkers will be also reported such as insulin concentration, Lipid profile, liver enzymes, c-peptide and glycated hemoglobin

Completed

Looking for future studies?

Notify Me

Key information

Age range

30 year–55 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Early Phase 1

Primary location

Soad A. Mohamad

Minya, 05673, Egypt

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • diabetic patients type 2

Exclusion criteria

  • liver failure
  • heart failure
  • renal failure

Treatment and study plan

MorDom

Dietary Supplement

oral powder in tea bags contains 4gm twice daily (equal concentration of each drugs)

Primary outcomes

  1. Blood glucose level

    Time frame: 3 months

    measured by fast blood test

Secondary outcomes

  1. blood level of lipid profile

    Time frame: two weeks

    Blood samples were drawn to measure levels of LDL, HDL, triglycerides, total cholesterol

  2. Liver enzymes

    Time frame: two weeks

    Blood samples were drawn to measure levels of ALT and AST

  3. C-peptide level

    Time frame: two weeks

    Blood samples were drawn to measure fasting and postprandial levels of c-peptide

  4. Insulin level

    Time frame: two weeks

    Blood samples were drawn to measure fasting and postprandial levels of insulin

Sponsors and collaborators

Lead sponsor

Deraya University

Other

Registry information

Official study title

Antidiabetic Potential of Hyphanea Thebaica Fruits and Moringa Olifera Leaves

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Jun 12, 2023
Registry last updated
Sep 26, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.